On Thursday 07/18/2024 the closing price of the Herbalife Ltd. share was $11.57 on BTT.
Compared to the opening price on Thursday 07/18/2024 on BTT of $11.41, this is a gain of 1.38%.
Herbalife Ltd.'s market capitalization is $1.12 B by 99.97 M shares outstanding.
Is Herbalife stock a Buy, Sell or Hold?
Herbalife stock has received a consensus rating of hold. The average rating score is and is based on 3 buy ratings, 9 hold ratings, and 2 sell ratings.What was the 52-week low for Herbalife stock?
The low in the last 52 weeks of Herbalife stock was 6.68. According to the current price, Herbalife is 167.29% away from the 52-week low.What was the 52-week high for Herbalife stock?
The high in the last 52 weeks of Herbalife stock was 19.48. According to the current price, Herbalife is 57.37% away from the 52-week high.What are analysts forecasts for Herbalife stock?
The 14 analysts offering price forecasts for Herbalife have a median target of 15.39, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate represents a 72.60 difference from the last price of 11.18.Herbalife Stock Snapshot
11.15
Bid
700.00
Bid Size
11.18
Ask
110.00
Ask Size
7/19/2024
Date
3:59 PM
Time
0.00
Volume
11.57
Prev. Close
0.00
Open
99.97 M
Number of Shares
6.68
52 Week Low
19.48
52 Week High
11.18
0.00
Dividend in USD
0.00
Dividend Yield
10.75
P/E Ratio
96.72
Free Float in %
1.44
EPS in USD
-10.69
Book Value per Share in USD
3.57
Cash Flow per Share in USD
Herbalife News More News
Historical Prices for Herbalife
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Herbalife Analyst Data
Total Analysts: 14
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 8.00
Median: 15.39
Highest: 30.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Herbalife Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
06/07/24 | Mizuho | Maintained Hold | $11 | |||
05/02/24 | D.A. Davidson & Co. | Maintained Hold | $9.5 | |||
03/25/24 | D.A. Davidson & Co. | Maintained Hold | $9.5 | |||
03/21/24 | Bank of America Merrill Lynch | Maintained Sell | $8 | |||
03/21/24 | Mizuho | Maintained Hold | $10 | |||
02/16/24 | Mizuho | Maintained Hold | $12 | |||
11/29/23 | Mizuho | Maintained Hold | $14 | |||
09/14/23 | D.A. Davidson & Co. | Maintained Hold | $13.5 | |||
08/03/23 | Mizuho | Maintained Hold | $17 | |||
06/07/23 | Mizuho | Maintained Hold | $13 | |||
03/01/23 | Citigroup Corp. | Maintained Buy | $28 | |||
02/03/23 | Bank of America Merrill Lynch | Maintained Sell | $14 | |||
11/01/22 | Citigroup Corp. | Maintained Buy | $26 | |||
10/05/22 | Citigroup Corp. | Maintained Buy | $30 |
Herbalife Estimates* in USD
2024 | 2025 | 2026 | |
---|---|---|---|
Revenue | 5,129 | 5,338 | 5,597 |
Dividend | - | - | 0.00 |
Dividend Yield (in %) | - | - | 0.00 % |
EPS | 1.62 | 2.17 | 3.13 |
P/E Ratio | 6.91 | 5.16 | 3.57 |
EBIT | 420 | 501 | 586 |
EBITDA | 557 | 632 | 726 |
Net Profit | 139 | 207 | 295 |
Net Profit Adjusted | 154 | 207 | 295 |
Pre-Tax Profit | 218 | 285 | 393 |
Net Profit (Adjusted) | - | - | - |
EPS (Non-GAAP) ex. SOE | 1.62 | 2.17 | 3.13 |
EPS (GAAP) | 1.26 | 2.07 | - |
Gross Income | 3,958 | 4,130 | - |
Cash Flow from Investing | 1 | 0 | - |
Cash Flow from Operations | 261 | 326 | - |
Cash Flow from Financing | 1 | 0 | - |
Cash Flow per Share | 2.96 | 3.67 | - |
Free Cash Flow | 117 | 180 | - |
Free Cash Flow per Share | - | - | - |
Book Value per Share | -9.50 | -7.95 | - |
Net Debt | - | - | - |
Research & Development Exp. | - | - | - |
Capital Expenditure | 141 | 146 | - |
Selling, General & Admin. Exp. | 1,862 | 1,900 | - |
Shareholder’s Equity | -945 | -735 | - |
Total Assets | - | - | - |
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 5 | 5 | 5 | 6 | 6 |
Average Estimate | 0.413 USD | 0.462 USD | 0.223 USD | 1.618 USD | 2.168 USD |
Year Ago | 0.604 USD | 0.431 USD | 0.103 USD | 1.436 USD | - |
Publish Date | 7/31/2024 | 10/29/2024 | 2/25/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | 5 | 5 | 5 | 5 | 5 |
Average Estimate | 1,329 USD | 1,295 USD | 1,241 USD | 5,129 USD | 5,338 USD |
Year Ago | 1,314 USD | 1,281 USD | 1,215 USD | 5,062 USD | - |
Publish Date | 7/31/2024 | 10/29/2024 | 2/25/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 5,062.40 | 5,204.40 | 5,802.80 | 5,541.80 | 4,877.10 | 4,891.80 | 4,427.70 |
Change of sales in % | -2.73 | -10.31 | 4.71 | 13.63 | -0.30 | 10.48 | -1.35 |
Gross profit on sales | 3,780.60 | 3,948.00 | 4,479.40 | 4,308.50 | 3,843.80 | 3,888.10 | 3,499.50 |
Gross profit on sales change in % | -4.24 | -11.86 | 3.97 | 12.09 | -1.14 | 11.10 | -1.10 |
Operating income | 320.10 | 536.10 | 730.80 | 744.90 | 531.90 | 659.60 | 577.70 |
Operating income change in % | -40.29 | -26.64 | -1.89 | 40.05 | -19.36 | 14.18 | 42.05 |
Income before tax | 203.00 | 424.80 | 560.80 | 516.40 | 451.40 | 464.20 | 471.20 |
Income before tax change in % | -52.21 | -24.25 | 8.60 | 14.40 | -2.76 | -1.49 | 29.20 |
Income after tax | 142.20 | 321.30 | 447.20 | 372.60 | 311.00 | 296.60 | 213.90 |
Income after tax change in % | -55.74 | -28.15 | 20.02 | 19.81 | 4.86 | 38.66 | -17.73 |
Balance Sheet in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 3,869.70 | 3,997.90 | 4,211.30 | 3,932.20 | 3,068.60 | 3,513.20 | 3,229.80 |
Long-term liabilities per share | 26.13 | 30.86 | 31.06 | 23.35 | 15.31 | 13.48 | 14.11 |
Equity | -1,060.30 | -1,265.90 | -1,391.50 | -856.10 | -390.00 | -723.40 | -334.70 |
Equity change in % | 16.24 | 9.03 | -62.54 | -119.51 | 46.09 | -116.13 | -270.50 |
Balance sheet total | 2,809.40 | 2,732.00 | 2,819.80 | 3,076.10 | 2,678.60 | 2,789.80 | 2,895.10 |
Balance sheet total change in % | 2.83 | -3.11 | -8.33 | 14.84 | -3.99 | -3.64 | 12.85 |
Key Data in USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 50.52 | 52.31 | 53.58 | 41.20 | 34.44 | 32.72 | 26.71 |
P/E ratio (year end quote, basic EPS) | 10.75 | 4.61 | 9.91 | 17.34 | 21.70 | 29.71 | 26.25 |
P/E ratio (year end quote, diluted EPS) | 10.75 | 4.61 | 9.91 | 17.34 | 21.70 | 29.71 | 26.25 |
P/E ratio (year end quote) | 10.75 | 4.61 | 9.91 | 17.34 | 21.70 | 29.71 | 26.25 |
Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity ratio in % | -37.74 | -46.34 | -49.35 | -27.83 | -14.56 | -25.93 | -11.56 |
Debt ratio in % | 137.74 | 146.34 | 149.35 | 127.83 | 114.56 | 125.93 | 111.56 |
Herbalife Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Mendoza Juan Miguel | 05/09/2024 | 7,000.00 | 93,279.00 | 10.65 | Buy | No |
Mendoza Juan Miguel | 05/08/2024 | 5,500.00 | 86,279.00 | 10.59 | Buy | No |
Mendoza Juan Miguel | 05/07/2024 | 2,500.00 | 80,779.00 | 10.17 | Buy | No |
Mendoza Juan Miguel | 05/06/2024 | 5,000.00 | 78,279.00 | 9.73 | Buy | No |
Mendoza Juan Miguel | 05/05/2024 | 3,000.00 | 73,279.00 | 9.67 | Buy | No |
Irani Jehangir D | 05/03/2024 | 3,726.00 | 66,573.00 | 9.58 | Sell | No |
Lamberti Frank | 05/03/2024 | 2,019.00 | 248,838.00 | 9.58 | Sell | No |
Montesino Ibelis | 05/03/2024 | 2,019.00 | 160,812.00 | 9.58 | Sell | No |
Irani Jehangir D | 05/02/2024 | 31,315.00 | 70,299.00 | n/a | Buy | No |
Lamberti Frank | 05/02/2024 | 36,534.00 | 250,857.00 | n/a | Buy | No |
Carmona Richard H | 05/02/2024 | 15,657.00 | 49,909.00 | n/a | Buy | No |
Del Genes Celine | 05/02/2024 | 15,657.00 | 33,961.00 | n/a | Buy | No |
Montesino Ibelis | 05/02/2024 | 26,096.00 | 162,831.00 | n/a | Buy | No |
LeFevre Alan W | 05/02/2024 | 18,266.00 | 69,117.00 | n/a | Buy | No |
Gratziani Stephan Paulo | 05/02/2024 | 60,020.00 | 137,796.00 | n/a | Buy | No |
Otero Maria | 05/02/2024 | 15,657.00 | 58,193.00 | n/a | Buy | No |
L'Helias Sophie | 05/02/2024 | 15,657.00 | 43,746.00 | n/a | Buy | No |
Mulligan Donal L | 05/02/2024 | 15,657.00 | 35,246.00 | n/a | Buy | No |
Mulligan Donal L | 05/02/2024 | 30,000.00 | 60,000.00 | 9.65 | Buy | No |
Macadrai Rodica | 03/25/2024 | 5,332.00 | 18,048.00 | 9.40 | Buy | No |
Mendoza Juan Miguel | 03/25/2024 | 16,079.00 | 54,622.00 | 9.40 | Buy | No |
Wang Henry C | 03/25/2024 | 2,778.00 | 176,194.00 | 9.30 | Buy | No |
Del Genes Celine | 03/25/2024 | 1,888.00 | 18,304.00 | 9.42 | Buy | No |
Macadrai Rodica | 03/10/2024 | 5,175.00 | 12,716.00 | 9.31 | Buy | No |
Mendoza Juan Miguel | 03/10/2024 | 4,421.00 | 38,543.00 | 9.14 | Buy | No |
Herbalife Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2022 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2021 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2020 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2019 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2018 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2017 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2016 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2015 | Herbalife Ltd. | 0.00 | 0.00 | USD |
2014 | Herbalife Ltd. | 0.15 | 0.80 | USD |
2013 | Herbalife Ltd. | 0.60 | 1.52 | USD |
2012 | Herbalife Ltd. | 0.60 | 3.64 | USD |
2011 | Herbalife Ltd. | 0.36 | 1.40 | USD |
2010 | Herbalife Ltd. | 0.23 | 1.32 | USD |
2009 | Herbalife Ltd. | 0.20 | 1.97 | USD |
*Yield of the Respective Date
Herbalife Ltd. Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 0.413 USD | Q2 2024 Earnings Release | 07/31/2024 |
Press Conference | - | 07/31/2024 | |
Earnings Report | 0.462 USD | Q3 2024 Earnings Release | 10/29/2024 |
Earnings Report | 0.223 USD | Q4 2024 Earnings Release | 02/25/2025 |
Earnings Report | 0.454 USD | Q1 2025 Earnings Release | 05/06/2025 |
Earnings Report | 0.690 USD | Q2 2025 Earnings Release | 08/05/2025 |
Herbalife Ltd. Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Annual General Meeting | - | Annual General Meeting | 04/25/2024 |
Herbalife Profile
Herbalife Ltd. is a holding company, which engages in the provision of health and wellness products. It operates through the following geographical segments: North America, Latin America, EMEA, Asia Pacific, and China. The company was founded by Mark Reynolds Hughes in February 1980 and is headquartered in Los Angeles, CA.
Moody���s Daily Credit Risk Score
Herbalife Shareholder
Owner | in % |
---|---|
Freefloat | 96.72 |
Route One Investment Co. LP | 10.31 |
The Vanguard Group, Inc. | 10.26 |
Vanguard Group, Inc. (Subfiler) | 9.96 |
The WindAcre Partnership LLC | 9.21 |
The WindAcre Partnership LLC | 8.91 |
Route One Investment Co. LP | 8.63 |
Renaissance Technologies LLC | 5.96 |
State Street Corp. | 5.94 |
Renaissance Technologies LLC | 5.93 |
UBS Group AG (13f Subfiler) | 5.28 |
Morgan Stanley Capital Services LLC | 5.06 |
BlackRock Fund Advisors | 3.61 |
BMO Bank NA (Investment Management) | 3.27 |
Camber Capital Management LP | 3.00 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.